(Q37024519)

17 August 2017

1 reference

title

Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer (English)

1 reference

17 August 2017

0 references

1 reference

Colin S Cooper

1

1 reference

17 August 2017

Colin Campbell

series ordinal

2

1 reference

17 August 2017

Sameer Jhavar

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

17 August 2017

Nature Reviews Urology

1 reference

17 August 2017

4

1 reference

17 August 2017

12

1 reference

17 August 2017

677-687

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpuro0946

17 August 2017

0 references

cites work

Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

Molecular markers of prostate cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Understanding and appreciating overdiagnosis in the PSA era

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Gene expression profiling predicts clinical outcome of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Detailed mapping of prostate carcinoma foci: biopsy strategy implications.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Heterogeneity of prostate cancer in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Evidence of independent origin of multiple tumors from patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Delineation of prognostic biomarkers in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

The latent process decomposition of cDNA microarray data sets

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

A Bayesian regression approach to the inference of regulatory networks from gene expression data

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Identification of prognostic signatures in breast cancer microarray data using Bayesian techniques.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

PRAC: A novel small nuclear protein that is specifically expressed in human prostate and colon

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

PRAC2: A new gene expressed in human prostate and prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

The polycomb group protein EZH2 is involved in progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

EZH2 promotes proliferation and invasiveness of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Hepsin promotes prostate cancer progression and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Defining aggressive prostate cancer using a 12-gene model

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Expression signatures that correlated with Gleason score and relapse in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

A molecular signature of metastasis in primary solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Stem cell-ness: a "magic marker" for cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

miRNAs, cancer, and stem cell division

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

MicroRNA expression profiles classify human cancers

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

A microRNA expression signature of human solid tumors defines cancer gene targets

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

MicroRNA expression profiling in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Gene expression correlates of clinical prostate cancer behavior

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0946

7 January 2021

Identifiers

DOI

10.1038/NCPURO0946

1 reference

17 August 2017

1 reference